Guyasuta Investment Advisors’s Novo Nordisk NVO Stock Holding History

Guyasuta Investment Advisors’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8,537	Closed	-$314K	–	283
2026 Q1	$314K	Hold	8,537	–	–	0.02%	224
2025 Q4	$434K	Hold	8,537	–	–	0.02%	178
2025 Q3	$474K	Sell	8,537 -1,149	-12%	-$67.3K	0.03%	170
2025 Q2	$669K	Hold	9,686	–	–	0.04%	147
2025 Q1	$673K	Hold	9,686	–	–	0.04%	140
2024 Q4	$833K	Hold	9,686	–	–	0.05%	130
2024 Q3	$1.15M	Sell	9,686 -3,364	-26%	-$449K	0.07%	106
2024 Q2	$1.35M	Hold	13,050	–	–	0.1%	96
2024 Q1	$1.35M	Hold	13,050	–	–	0.1%	96
2023 Q4	$1.35M	Hold	13,050	–	–	0.1%	96
2023 Q3	$1.19M	Hold	13,050	–	–	0.09%	96
2023 Q2	$1.06M	Hold	13,050	–	–	0.08%	99
2023 Q1	$1.04M	Sell	13,050 -1,450	-10%	-$103K	0.08%	101
2022 Q4	$981K	Hold	14,500	–	–	0.08%	105
2022 Q3	$722K	Hold	14,500	–	–	0.06%	117
2022 Q2	$808K	Hold	14,500	–	–	0.06%	132
2022 Q1	$805K	Hold	14,500	–	–	0.06%	147
2021 Q4	$812K	Hold	14,500	–	–	0.05%	147
2021 Q3	$696K	Hold	14,500	–	–	0.05%	155
2021 Q2	$607K	Hold	14,500	–	–	0.04%	164
2021 Q1	$489K	Hold	14,500	–	–	0.04%	174
2020 Q4	$506K	Hold	14,500	–	–	0.04%	161
2020 Q3	$503K	Hold	14,500	–	–	0.05%	147
2020 Q2	$475K	Hold	14,500	–	–	0.05%	147
2020 Q1	$436K	Hold	14,500	–	–	0.05%	133
2019 Q4	$420K	Hold	14,500	–	–	0.04%	158
2019 Q3	$375K	Hold	14,500	–	–	0.04%	158
2019 Q2	$370K	Hold	14,500	–	–	0.04%	161
2019 Q1	$379K	Hold	14,500	–	–	0.04%	154
2018 Q4	$334K	Hold	14,500	–	–	0.04%	158
2018 Q3	$342K	Hold	14,500	–	–	0.04%	174
2018 Q2	$334K	Hold	14,500	–	–	0.04%	171
2018 Q1	$357K	Hold	14,500	–	–	0.04%	171
2017 Q4	$389K	Hold	14,500	–	–	0.04%	171
2017 Q3	$349K	Hold	14,500	–	–	0.04%	169
2017 Q2	$311K	Hold	14,500	–	–	0.04%	172
2017 Q1	$249K	Hold	14,500	–	–	0.03%	193
2016 Q4	$260K	Hold	14,500	–	–	0.03%	190
2016 Q3	$302K	Sell	14,500 -1,500	-9%	-$37.2K	0.04%	169
2016 Q2	$430K	Hold	16,000	–	–	0.06%	144
2016 Q1	$433K	Hold	16,000	–	–	0.06%	144
2015 Q4	$464K	Hold	16,000	–	–	0.07%	137
2015 Q3	$433K	Hold	16,000	–	–	0.06%	150
2015 Q2	$438K	Buy	+16,000	New	+$450K	0.06%	160

Other funds holding NVO

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

EHC

Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SRIM

Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return

Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

Guyasuta Investment Advisors's NVO Position: Q2 2026 in Review

Guyasuta Investment Advisors sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 8,537 shares — an estimated $314K sold.

Guyasuta Investment Advisors first reported a position in NVO in Q2 2015 and held it in 44 quarters. The position peaked at $1.35M in Q2 2024. 819 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Guyasuta Investment Advisors reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
Guyasuta Investment Advisors sold 8,537 Novo Nordisk shares in Q2 2026, an estimated $314K.
Guyasuta Investment Advisors first reported a position in Novo Nordisk in Q2 2015 and held it in 44 quarters.
Guyasuta Investment Advisors's Novo Nordisk position peaked at $1.35M in Q2 2024.
819 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Guyasuta Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.